Noticias Imprimir 2026FDA approves immunotherapy regimen studied by Mayo Clinic for stage 3 colon cancer Oct. 09, 2026, 12:45 p.m. CDTImmunotherapy boosts chemotherapy in combating stage 3 colon cancer March 25, 2026, 10:05 p.m. CDT PST-20220972 Inicio Noticias